Personalized health company Newtopia closes $10 mln Series A

Personalized health platform Newtopia Inc has raised $10 million in a Series A financing. The round was led by a syndicate of U.S. and Canadian investors, including Bloom Burton & Co, an investment banking firm specializing in the health sector. Bloom Burton previously invested in the company in late 2014. Based in Toronto and New York, Newtopia uses genetic testing and behavioural science to build personalized disease prevention plans for the workplace. It plans to use the funds raised to expand its geographic reach in the United States. Founded in 2008 by CEO Jeff Ruby, Newtopia's other investors have included BDC Capital.

CanadaNorth AmericaBriefs